• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β上调人系膜细胞中的纤溶酶原激活物/纤溶酶系统。

Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells.

作者信息

Wilson H M, Haites N E, Reid F J, Booth N A

机构信息

Department of Molecular and Cell Biology, University of Aberdeen, Scotland, United Kingdom.

出版信息

Kidney Int. 1996 Apr;49(4):1097-104. doi: 10.1038/ki.1996.159.

DOI:10.1038/ki.1996.159
PMID:8691730
Abstract

The plasminogen activators (PA), which are regulated by their specific inhibitor, PAI-1, convert the zymogen plasminogen to plasmin, a protease involved in fibrinolysis and extracellular matrix turnover. Interleukin 1 beta (IL-1) is a key cytokine released from infiltrating monocytes/macrophages during the initial stages of glomerular injury. We investigated the effects of IL-1 on the production of tissue-type plasminogen activator (t-PA), urokinase (u-PA) and PAI-1 by glomerular cells. IL-1 significantly increased the synthesis of t-PA by mesangial cells and glomerular epithelial cells (P < 0.005 for both cell types), while u-PA production was unaltered. PAI-1 in mesangial cell supernatants was significantly lower when cultured in the presence of IL-1 (p < 0.008), and the synthesis decreased in a time and dose dependent manner. The effects of IL-1 were eliminated by anti-IL-1 neutralizing antibodies. The PAI-1 sequestered in the extracellular matrix of mesangial cells was also decreased. No significant change in PAI-1 synthesis by epithelial cells was observed with exogenous IL-1. Northern blot analysis paralleled the protein results, demonstrating an increase in t-PA and a decrease in PAI-1 mRNA of mesangial cells after 6 and 24 hours stimulation with 10 U/ml IL-1. These studies suggest a role for IL-1 in regulating localized proteolysis by mesangial cells during acute inflammation.

摘要

纤溶酶原激活剂(PA)受其特异性抑制剂PAI - 1的调节,可将酶原纤溶酶原转化为纤溶酶,纤溶酶是一种参与纤维蛋白溶解和细胞外基质更新的蛋白酶。白细胞介素1β(IL - 1)是肾小球损伤初始阶段浸润的单核细胞/巨噬细胞释放的关键细胞因子。我们研究了IL - 1对肾小球细胞组织型纤溶酶原激活剂(t - PA)、尿激酶(u - PA)和PAI - 1产生的影响。IL - 1显著增加了系膜细胞和肾小球上皮细胞t - PA的合成(两种细胞类型均P < 0.005),而u - PA的产生未改变。在IL - 1存在下培养时,系膜细胞上清液中的PAI - 1显著降低(p < 0.008),且合成呈时间和剂量依赖性下降。抗IL - 1中和抗体消除了IL - 1的作用。系膜细胞细胞外基质中隔离的PAI - 1也减少。外源性IL - 1未观察到上皮细胞PAI - 1合成有显著变化。Northern印迹分析结果与蛋白质结果一致,表明用10 U/ml IL - 1刺激6小时和24小时后,系膜细胞t - PA增加,PAI - 1 mRNA减少。这些研究表明IL - 1在急性炎症期间调节系膜细胞局部蛋白水解中起作用。

相似文献

1
Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells.白细胞介素-1β上调人系膜细胞中的纤溶酶原激活物/纤溶酶系统。
Kidney Int. 1996 Apr;49(4):1097-104. doi: 10.1038/ki.1996.159.
2
Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells.白细胞介素-1和转化生长因子-β对人系膜细胞组织型纤溶酶原激活物及纤溶酶原激活物抑制剂-1表达调控的相反作用
Exp Nephrol. 1997 May-Jun;5(3):233-8.
3
Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.肝素可选择性抑制人系膜细胞组织型纤溶酶原激活物的合成及纤溶酶原激活物抑制剂1的基质沉积。
Lab Invest. 1994 Dec;71(6):828-37.
4
Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.低密度脂蛋白对系膜细胞中纤溶酶原激活物/抑制剂的双相调节作用
Am J Physiol Renal Physiol. 2002 Sep;283(3):F423-30. doi: 10.1152/ajprenal.00304.2001.
5
Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.活性氧介导高糖诱导的系膜细胞和糖尿病肾脏中纤溶酶原激活物抑制剂-1的上调。
Kidney Int. 2005 May;67(5):1762-71. doi: 10.1111/j.1523-1755.2005.00274.x.
6
Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells.细胞因子诱导的组织型纤溶酶原激活物(tPA)表达在大鼠系膜细胞中受到一氧化氮(NO)和活性氧(ROS)的差异调节。
Kidney Int. 2002 Jan;61(1):20-30. doi: 10.1046/j.1523-1755.2002.00087.x.
7
Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.人牙龈组织和牙龈成纤维细胞中纤溶酶原激活物系统的免疫组织化学显示
J Periodontal Res. 1998 Jan;33(1):17-26. doi: 10.1111/j.1600-0765.1998.tb02287.x.
8
Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.纤溶酶原激活物抑制剂-1在培养的人系膜细胞细胞外基质中的沉积。
Am J Pathol. 1992 Jul;141(1):117-28.
9
Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.人肾小球系膜细胞对纤溶酶原激活物抑制剂1和组织型纤溶酶原激活物释放的细胞特异性调节。
Biochim Biophys Acta. 1992 Apr 7;1134(3):189-96. doi: 10.1016/0167-4889(92)90175-b.
10
Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells.血管紧张素II对大鼠系膜细胞中纤溶酶原/纤溶酶系统的双重作用。
Kidney Int. 1997 Mar;51(3):664-71. doi: 10.1038/ki.1997.96.

引用本文的文献

1
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.胰岛组织纤溶酶原激活物/纤溶酶系统在人胰岛淀粉样多肽聚集时上调,并保护β细胞免受聚集诱导的毒性。
Diabetologia. 2024 Sep;67(9):1897-1911. doi: 10.1007/s00125-024-06161-0. Epub 2024 Sep 9.
2
Roles of the tissue-type plasminogen activator in immune response.组织型纤溶酶原激活物在免疫应答中的作用。
Cell Immunol. 2022 Jan;371:104451. doi: 10.1016/j.cellimm.2021.104451. Epub 2021 Nov 6.
3
The emerging role of coagulation proteases in kidney disease.
凝血蛋白酶在肾脏疾病中的新作用。
Nat Rev Nephrol. 2016 Feb;12(2):94-109. doi: 10.1038/nrneph.2015.177. Epub 2015 Nov 23.
4
Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.诱导白细胞介素-1受体拮抗剂的基质金属蛋白酶-3对于上调II型胶原蛋白和聚集蛋白聚糖以及下调含血小板解聚蛋白样金属蛋白酶-5(ADAMTS-5)基因表达是必需的。
Arthritis Res Ther. 2012 Sep 11;14(5):R197. doi: 10.1186/ar4033.